Pharmafile Logo
Pharmafocus logo
Advanced Search

MSD sways NICE with Simponi patient access scheme

August 26, 2011
Sales and Marketing NICE, Simponi, ankylosing spondylitis

A patient access scheme which lowers Simponi’s cost has led to Merck Sharp and Dohme’s drug being given the thumbs …

News
Boehringer - Lilly's Trajenta (linagliptin)

Boehringer-Lilly’s Trajenta wins European approval

August 26, 2011
Sales and Marketing Tradjenta, Trajenta, diabetes

Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been approved Europe. The European Commission backed Trajenta …

News

Reckitt painkiller packs may contain antipsychotics, says MHRA

August 26, 2011
Manufacturing and Production, Sales and Marketing MHRA, Nurofen, Seroquel, parallel imports

Consumers in the UK are being warned to double-check packs of Reckitt Benckiser’s painkiller product Nurofen Plus following reports that …

News
rock_medical_communications_ash_rishi

Rock adds four new starters

August 26, 2011
Medical Communications appointments, medical communications

Rock Medical Communications has appointed four new people to its specialist medical education team. Sam Flynn joins as account manager …

Appointment

Google fined $500m for online drug advertising

August 26, 2011
Medical Communications, Sales and Marketing Google Adwords, counterfeits, google

Google has been fined $500 million by the US government for allowing pharmacies based in Canada to advertise unlicenced drugs …

News

AkzoNobel appoints new investor relations director

August 25, 2011
Sales and Marketing appointment, sales and marketing

Jonathan Atack is set to join AkzoNobel as the company’s new corporate director of investor relations. He was most recently …

Appointment

Market access and the new NHS in England

August 25, 2011
Sales and Marketing NHS, NHS reforms

The National Health Service in England is undergoing massive structural and financial upheaval, and pharma marketers will be rightly concerned …

Feature
Diabetes injection

Sharp increase in NHS diabetes prescribing costs

August 25, 2011
Sales and Marketing GP prescribing, NHS, diabetes, prescribing

NHS prescribing for diabetes has risen sharply, largely driven by the disease’s growing prevalence in the UK. Spending rose 41% …

News

NICE says no to BMS for second-line Orencia

August 25, 2011
Sales and Marketing BMS, NICE, Orencia, rheumatoid arthritis

In final draft guidance NICE has not recommended the use of Bristol-Myers Squibb’s arthritis drug Orencia after other drugs have …

News

inVentiv Health consolidates Europe agencies

August 25, 2011
Medical Communications inVentiv Health, medical communications news

Communications group inVentiv has launched a new company which brings together all of its healthcare services under one roof. inVentiv …

News

FDA approves Botox to treat urinary incontinence

August 25, 2011
Sales and Marketing Allergan, Botox, urinary incontinence

Botox has been approved in the US to treat urinary incontinence as manufacturer Allergan continues to expand the brand’s non-cosmetic …

News

Clinical research news in brief

August 24, 2011
Research and Development contract research news, research and development news

Private equity firm the Carlyle Group is rumoured to be looking at buying PPD, plus there are updates from CTA/Clininvent, …

News

AZ details US doctor payments

August 24, 2011
Sales and Marketing AstraZeneca, industry reputation, payments

AstraZeneca is shining a light on its activities in the US, disclosing for the first time how much it pays …

News

Spain to cut 2.4 billion euros from drugs bill with new generics rules

August 24, 2011
Sales and Marketing Spain, generic prescribing, generics

The Spanish government has passed new laws to increase generic prescribing and cut billions of euros from the country’s drugs …

News

Blood cancer drug Adcetris approved by FDA

August 24, 2011
Sales and Marketing Adcetris, Cancer, Seattle Genetics, lymphoma

The FDA has approved Seattle Genetics’ blood cancer drug Adcetris for two forms of lymphoma. Adcetris (brentuximab vedotin) can now …

News
quintiles_consulting_troy_norris

Quintiles appoints Troy Norris to head up consulting group

August 24, 2011
Research and Development appointment, research and development

Troy Norris has joined Quintiles as vice president and managing director for the product development and commercialisation practice at its …

Appointment

UK research receives £800m funding boost

August 23, 2011
Research and Development NIHR, UK research, UK science, research and development news

Research into dementia, cancer, diabetes and heart disease are among the activities to benefit from a new £800 government funding …

News
zaicom_anagaskill_1

Zaicom Medical Marketing Communications appoints Ana Gaskill

August 23, 2011
Medical Communications appointment, medical communications

Zaicom Medical Marketing Communications (Zaicom MMC) has appointed Ana Gaskill as an account director. She joins the West Sussex, UK-based …

Appointment
Digital communications

Healthcare communications – how to influence behaviour change

August 23, 2011
Medical Communications communications, healthcare communications

For decades, healthcare communications has used a fixed way of approaching patients and customers. But now we must adopt new …

Feature
Bayer

FDA fast tracks Bayer prostate cancer drug

August 23, 2011
Sales and Marketing Algeta, Alpharadin, Bayer, prostate cancer

Bayer’s potential blockbuster prostate cancer drug Alpharadin has been granted a fast track review by the FDA, meaning it could …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026